{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:52:15Z","timestamp":1784332335813,"version":"3.55.0"},"reference-count":65,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Interior Universities Research Coalition (IURC) Ministry of Health","award":["451078"],"award-info":[{"award-number":["451078"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Can J Psychiatry"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The drug poisoning crisis throughout North America necessitates novel harm reduction approaches. Emerging evidence suggests that cannabidiol (CBD) may have some utility as a harm reduction modality for those with problematic substance use. This rapid review aimed to synthesize available evidence on CBD as a potential harm reduction tool for people who use drugs while providing clinical and research insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A systematic search in EMBASE, MEDLINE, CENTRAL, and CINAHL was completed in July 2022. For inclusion, studies had to meet the following criteria: (1) drawn from an adult population of people who use drugs; (2) investigates CBD as an intervention for problematic substance use or harm reduction\u2013related outcomes; (3) be published after the year 2000 and in English; and (4) be primary research or a review article. A narrative synthesis was used to group outcomes relevant to harm reduction and provide clinical and research insights.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We screened 3,134 records, of which 27 studies (5 randomized trials) were included. The evidence remains limited, but available studies support the potential utility of CBD to reduce drug-induced craving and anxiety in opioid use disorder. There were low-quality studies suggesting that CBD may improve mood and general well-being of people who use drugs. Evidence suggests that CBD monotherapy may not be an adequate harm reduction strategy for problematic substance use but rather an adjunct to the standard of care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Low-quality evidence suggests that CBD may reduce drug cravings and other addiction-related symptoms and that CBD may have utility as an adjunct harm reduction strategy for people who use drugs. However, there is a significant need for more research that accurately reflects CBD dosing and administration regimens used in a real-world context.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/07067437231183525","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T02:50:46Z","timestamp":1687920646000},"page":"557-571","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review"],"prefix":"10.1177","volume":"68","author":[{"given":"Lindsay A.","family":"Lo","sequence":"first","affiliation":[{"name":"Department of Public Health Sciences, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-3959","authenticated-orcid":false,"given":"Caroline A.","family":"MacCallum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1739-9121","authenticated-orcid":false,"given":"Kate","family":"Nanson","sequence":"additional","affiliation":[{"name":"School of Nursing, Thompson Rivers University, Kamloops, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-2574","authenticated-orcid":false,"given":"Michael","family":"Koehn","sequence":"additional","affiliation":[{"name":"The CannSolve Clinic, Kamloops, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael-John","family":"Milloy","sequence":"additional","affiliation":[{"name":"BC Centre on Substance Use and Department of Medicine, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zach","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of British Columbia, Kelowna, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florriann","family":"Fehr","sequence":"additional","affiliation":[{"name":"School of Nursing, Thompson Rivers University, Kamloops, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"key":"bibr1-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.07.1052"},{"key":"bibr2-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12275"},{"key":"bibr3-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0183-9"},{"key":"bibr4-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.04.006"},{"key":"bibr5-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2017.04.026"},{"key":"bibr6-07067437231183525","doi-asserted-by":"publisher","DOI":"10.2174\/157015906778019527"},{"key":"bibr7-07067437231183525","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2021.306168"},{"key":"bibr8-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0229"},{"key":"bibr9-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.626010"},{"key":"bibr10-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.8.1483"},{"key":"bibr11-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15060710"},{"key":"bibr12-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21218"},{"key":"bibr13-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2020.1754793"},{"key":"bibr14-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2018.07.027"},{"key":"bibr15-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2011.04.017"},{"key":"bibr16-07067437231183525","unstructured":"Health Canada. Apparent opioid-related deaths. aem. 2017 Sep 14 [accessed 2018 Sep 18]. https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/problematic-prescription-drug-use\/opioids\/apparent-opioid-related-deaths.html."},{"key":"bibr17-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100633"},{"key":"bibr18-07067437231183525","unstructured":"Health Canada. Opioid- and stimulant-related harms in Canada. 2022 [accessed 2022 Mar 25]. https:\/\/health-infobase.canada.ca\/substance-related-harms\/opioids-stimulants\/."},{"key":"bibr19-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.10.007"},{"key":"bibr20-07067437231183525","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135"},{"key":"bibr21-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008"},{"key":"bibr22-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1186\/s41073-019-0064-8"},{"key":"bibr23-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"bibr24-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2020.03.002"},{"key":"bibr25-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuro.2019.08.002"},{"key":"bibr26-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05712-8"},{"key":"bibr27-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2021.06.002"},{"key":"bibr28-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0373-7"},{"key":"bibr29-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2019.18101191"},{"key":"bibr30-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2022.108948"},{"key":"bibr31-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0089"},{"key":"bibr32-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1159\/000521683"},{"key":"bibr33-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2021.05.044"},{"key":"bibr34-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2020-1416"},{"key":"bibr35-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.712110"},{"key":"bibr36-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000959"},{"key":"bibr37-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1111\/add.15417"},{"key":"bibr38-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.565617"},{"key":"bibr39-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00063"},{"key":"bibr40-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2022.107360"},{"key":"bibr41-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2022.173376"},{"key":"bibr42-07067437231183525","first-page":"6","volume":"3","author":"Shaw C","year":"2021","journal-title":"Am J Endocannabinoid Med"},{"key":"bibr43-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2017.05.031"},{"key":"bibr44-07067437231183525","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2020.22.3\/rspanagel"},{"key":"bibr45-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102737"},{"key":"bibr46-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1089\/can.2018.0022"},{"key":"bibr47-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1089\/imr.2022.0070"},{"key":"bibr48-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2022.2120425"},{"key":"bibr49-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-022-00446-8"},{"key":"bibr50-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13710"},{"key":"bibr51-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00073-1"},{"key":"bibr52-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.05.002"},{"key":"bibr53-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1177\/07067437211037625"},{"key":"bibr54-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.01969"},{"key":"bibr55-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1097\/FBP.0000000000000565"},{"key":"bibr56-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1089\/can.2021.0058"},{"key":"bibr57-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/j.jopan.2009.10.002"},{"key":"bibr58-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.816"},{"issue":"6","key":"bibr59-07067437231183525","first-page":"535","volume":"10","author":"Rabbani M","year":"2015","journal-title":"Res Pharm Sci."},{"key":"bibr60-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.699666"},{"key":"bibr61-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1078\/094471102321621304"},{"key":"bibr62-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4603(96)00042-1"},{"key":"bibr63-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-019-0012-y"},{"key":"bibr64-07067437231183525","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041863"},{"key":"bibr65-07067437231183525","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1387"}],"container-title":["The Canadian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/07067437231183525","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/07067437231183525","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/07067437231183525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:15:13Z","timestamp":1777392913000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/07067437231183525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1177\/07067437231183525"],"URL":"https:\/\/doi.org\/10.1177\/07067437231183525","relation":{},"ISSN":["0706-7437","1497-0015"],"issn-type":[{"value":"0706-7437","type":"print"},{"value":"1497-0015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]}}}